← Open Payments lookup

DUKE NYARECHA: Open Payments

NPI 1235625914 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$716 in 33 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $58 · 2025 $716

Food & beverage: $716
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$341
Otsuka America Pharmaceutical, Inc.4$86
E.R. Squibb & Sons, L.L.C.3$67
Vanda Pharmaceuticals Inc.2$58
Janssen Pharmaceuticals, Inc3$53
ABBVIE INC.3$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Lundbeck LLC1$16
Alkermes, Inc.1$16
Teva Pharmaceuticals USA, Inc.1$14

Products named: INGREZZA, COBENFY, ABILIFY ASIMTUFII, FANAPT, INVEGA SUSTENNA, VRAYLAR, REXULTI, CAPLYTA.

Industry payments across ID — which companies pay providers there.